ISRAEL-INDIA Business Guide | Medical Technology, Pharma & Biotech

26 / 40

26 Israel-India Business Guide - MedTech, Pharma & Biotech
• The BreathID System developed by Exalenz Bioscience
is a platform technology used to assess a range of liver
and gastrointestinal disorders via molecular analysis of
the patient’s breath.
• Smart Biotech’s SMARTube stimulates antibody
production (in vitro) for early and more complete
detection of HIV and HCV than current antibody tests.
Therapeutics & Stem Cells
Scientists from the Weizmann Institute of Science,
the Technion-Israel Institute of Technology, other
outstanding research institutions, and the country’s strong
pharmaceutical and biotechnology industries drive the
17% annual growth the Israeli biotechnology sector has
seen in the past decade. A recognized world leader in
biopharmaceuticals, Israeli breakthrough therapeutics can
be found in the treatment of cancer, multiple sclerosis,
Parkinson’s and Alzheimer’s diseases, diabetes, and more.
Israel stands at the forefront of stem cell research that has
led to more than 20 active stem cell companies.
• Biopharmaceuticals by industry leader Kamada rely
on patented protein purification technology to treat
respiratory diseases and critical care illnesses.
• Se-cure Pharmaceuticals has a unique platform for
developing botanical drugs, based on U.S. FDA guidelines,
to provide standardized, stable compounds for safe and
innovative targeted solutions for health needs.
• Cell therapies developed by Gamida Cell are used for
treating patients with blood cancers, autoimmune illnesses,
and metabolic, and ischemic vascular diseases.
• Pluristem Therapeutics is a clinical-stage biotechnology
company with proprietary technology for the development
and manufacture of non-personalized (allogeneic) cell
therapies derived from the human placenta. Its patented
and scalable PLX (PLacental eXpanded) cell products are
readily available for the treatment of critical limb ischemia
(CLI) and other diseases.
About The Israel Export &
International Cooperation Institute
The Israel Export & International Cooperation Institute (IEICI),
supported by member firms, private-sector bodies, and
the government of Israel, advances business relationships
between Israeli exporters and overseas businesses and
organizations. By providing a wide range of export-oriented
services to Israeli companies and complementary services
to the international business community, the Institute
helps build successful joint ventures, strategic alliances,
and trade partnerships. The IEICI’s Life Science Department
is the Israeli leader in business matching between Israeli
life science industry companies and worldwide business
partners at all levels. It has a proven ability to identify and
match suitable potential business partners, organize one-
on-one business meetings, and act as a focal point for
contacts with the government as well as with the industry.
For further information:
Mr. David Furst, Director, Life Science Industry
+972-3-514-2856,
Ms. Angelica Khachaturov, Business Development
Manager Medical Devices & Healthcare IT
+972-3-514-2986,
Mr. Ronen Gruber, Business Development Manager
Biotech, Pharmaceuticals & Nanotech
+972-2-514-2938,
Meeting global healthcare challenges MedTech